ISRG vs TSLA: How Intuitive Surgical and Tesla Compare (2026)
Short answer
ISRG (Intuitive Surgical) and TSLA (Tesla) are often compared because they share investment themes, but they are different businesses. Intuitive Surgical (ISRG) is the dominant maker of robotic-assisted surgery systems, best known for the da Vinci platform used in minimally invasive procedures across urology, gynecology, general surgery, and other specialties. Tesla is an electric-vehicle and clean-energy company, and one of the most closely watched stocks in the world. Neither is universally better: pick by which thesis you are expressing and what you already own. This is descriptive, not a recommendation.
What does Intuitive Surgical (ISRG) do?
Intuitive Surgical (ISRG) is the dominant maker of robotic-assisted surgery systems, best known for the da Vinci platform used in minimally invasive procedures across urology, gynecology, general surgery, and other specialties. Its business model is razor-and-blade: Intuitive sells or places the large capital systems, then earns high-margin recurring revenue from the single-use instruments and accessories consumed in each procedure, plus service contracts. As the installed base of systems grows and procedure volumes rise, recurring revenue compounds. The company has expanded its platform with newer systems (including the da Vinci 5 and the Ion platform for lung biopsy), and benefits from surgeon training, hospital workflow integration, and a large library of validated procedures that create high switching costs. Intuitive went public in 2000 and is headquartered in Sunnyvale, California. It is the clear leader in surgical robotics with a wide moat, strong margins, and consistent procedure-volume growth, though it trades at a premium valuation that reflects those qualities.
What does Tesla (TSLA) do?
Tesla is an electric-vehicle and clean-energy company, and one of the most closely watched stocks in the world. Its core business is designing, manufacturing, and selling electric cars (Model 3, Model Y, Model S, Model X, Cybertruck) along with the charging network and software that support them. Tesla also sells energy products: solar panels and battery storage systems (Powerwall for homes and Megapack for utilities and businesses). The company makes money primarily from vehicle sales, plus a growing energy-storage business, regulatory credits, and software and services (including its driver-assistance features). Tesla is also pursuing ambitious longer-term bets: full self-driving software, a robotaxi service, and a humanoid robot (Optimus), which bulls see as potential future value drivers far beyond cars. The stock often trades on these future ambitions as much as current automotive earnings. Led by Elon Musk, Tesla is headquartered in Austin, Texas, and operates factories in the US, China, and Germany.
ISRG vs TSLA: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Intuitive Surgical is best understood through its own drivers, and Tesla through its. The useful comparison is which set of drivers and risks you want exposure to.
- ISRG drivers: Razor-and-blade recurring revenue; Installed base and switching costs.
- TSLA drivers: EV scale and manufacturing efficiency; Energy storage and generation.
ISRG or TSLA: which should you pick?
The bottom line: ISRG vs TSLA
ISRG and TSLA are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ISRG and TSLA exposure against your real portfolio. It is not an investment adviser.
Build a basket around ISRG with Walnut
Use Intuitive Surgical as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What is the difference between ISRG and TSLA?
+
Intuitive Surgical (ISRG) is the dominant maker of robotic-assisted surgery systems, best known for the da Vinci platform used in minimally invasive procedures across urology, gynecology, general surgery, and other specialties. Tesla is an electric-vehicle and clean-energy company, and one of the most closely watched stocks in the world. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is ISRG or TSLA the better stock?
+
Walnut is informational, not investment advice. Neither is universally better; ISRG and TSLA suit different views and risk levels. Compare what each does, how they make money, and the risks, then decide which fits your thesis and what you already own.
Should you own both ISRG and TSLA?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both before you add the second.
What are the risks of ISRG vs TSLA?
+
ISRG: ISRG trades at a premium valuation, so any slowdown in procedure growth, system placements, or margins can compress the multiple sharply. Competition is intensifying as Medtronic, Johnson & Johnson, and others develop rival surgical-robotics platforms that could erode Intuitive's dominance over time. Hospital capital budgets are cyclical and can defer system purchases in tight economic periods. Reimbursement changes, regulatory scrutiny of new systems, and any safety or recall issues are risks. The company is also exposed to global healthcare-spending trends and currency, and the high valuation leaves little room for execution missteps. TSLA: Tesla faces intensifying EV competition from legacy automakers and from Chinese manufacturers like BYD, pressuring prices and margins. Automotive demand is cyclical and sensitive to interest rates, incentives, and economic conditions, and Tesla has cut prices to defend volume, compressing margins. The stock trades at a very high valuation that prices in optimistic outcomes for autonomy, robotaxi, and Optimus, none of which is guaranteed to arrive on the expected timeline or scale, so disappointment can trigger sharp declines. Key-person risk around Elon Musk is significant, given his central role and divided attention across multiple ventures. Regulatory scrutiny of driver-assistance features, geopolitical exposure in China, and execution risk on ambitious new products add further uncertainty. Volatility is extreme.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ISRG or TSLA; figures are approximate and dated. Verify current data before investing.